Chemoinformaics analysis of (Z,Z)-Heptadeca-1,8,11-triene
Molecular Weight | 234.427 | nRot | 12 |
Heavy Atom Molecular Weight | 204.187 | nRig | 3 |
Exact Molecular Weight | 234.235 | nRing | 0 |
Solubility: LogS | -3.458 | nHRing | 0 |
Solubility: LogP | 5.533 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 48.3938 |
nHD | 0 | BPOL | 30.0962 |
QED | 0.278 |
Synth | 2.495 |
Natural Product Likeliness | 1.323 |
NR-PPAR-gamma | 0.343 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.02 |
CACO-2 | -4.856 |
MDCK | 0.0000379 |
BBB | 0.651 |
PPB | 0.992545 |
VDSS | 3.271 |
FU | 0.0066265 |
CYP1A2-inh | 0.583 |
CYP1A2-sub | 0.524 |
CYP2c19-inh | 0.533 |
CYP2c19-sub | 0.182 |
CYP2c9-inh | 0.356 |
CYP2c9-sub | 0.938 |
CYP2d6-inh | 0.729 |
CYP2d6-sub | 0.934 |
CYP3a4-inh | 0.792 |
CYP3a4-sub | 0.128 |
CL | 4.877 |
T12 | 0.91 |
hERG | 0.108 |
Ames | 0.265 |
ROA | 0.024 |
SkinSen | 0.971 |
Carcinogencity | 0.334 |
EI | 0.984 |
Respiratory | 0.925 |
NR-Aromatase | 0.026 |
Antiviral | Yes |
Prediction | 0.700449 |